LNA-CTP sodium salt

LNA-CTP sodium salt is a modified form of cytidine triphosphate (CTP) with an LNA modification incorporated into the ribose sugar moiety. This modification enhances the stability and binding affinity of CTP to complementary RNA or DNA targets. The sodium salt form enhances the solubility and stability of LNA-CTP, making it suitable for various molecular biology applications, including RNAi, antisense oligonucleotide therapeutics, and RNA-based diagnostics.

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Catalog

BRP-00654

Synonyms

4-Amino-1-[2,5-anhydro-4-C-(3,5,7,7-tetrahydroxy-3,5,7-trioxido-2,4,6-trioxa-3,5,7-triphosphahept-1-yl)-α-L-lyxofuranosyl]-2(1H)-pyrimidinone sodium salt

IUPAC Name

sodium;((1R,3R,4R,7S)-3-(4-amino-2-oxopyrimidin-1(2H)-yl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-1-yl)methyl tetrahydrogen triphosphate

Molecular Weight

495.17 (free acid)

Molecular Formula

C10H16N3O14P3 (free acid)

Purity

≥98%

Storage

Store at -20 °C, Always avoid freeze-thaw cycles

Related CAS

847650-98-0 (free acid)